Myasthenia gravis

G6_MYASTHENIA

Myasthenia gravis: Myasthenia gravis (MG) is a rare, clinically heterogeneous, autoimmune disorder of the neuromuscular junction characterized by fatigable weakness of voluntary muscles.

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 G70.0#
Hospital discharge: ICD-9 3580
Hospital discharge: ICD-8 7330
Cause of death: ICD-10 G70.0#
Cause of death: ICD-9 3580
Cause of death: ICD-8 7330
KELA reimbursements: KELA codes 108

3 out of 7 registries used, show all original rules.

442

diagram downward connector

Check minimum number of events None

442

diagram downward connector

Include endpoints None

442

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

426

diagram downward connector
G6_MYASTHENIA

Control definitions

Control exclude G6_MYONEU

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 G70

Summary Statistics

Key figures

All Female Male
Number of individuals 426 229 197
Unadjusted prevalence (%) 0.11 0.11 0.12
Mean age at first event (years) 52.67 47.28 58.93

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.02 1.12 [0.44, 2.84] 8.2e-1 46
15 years 0.00 0.74 [0.32, 1.70] 4.7e-1 16
5 years 0.00 2.17 [1.03, 4.58] 4.1e-2 13
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: G6_MYASTHENIA – Myasthenia gravis
GWS hits: 1

Survival analyses between endpoints

Plot

before Myasthenia gravis
after Myasthenia gravis

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Myasthenia gravis

Endpoint not on priority list, no data to show.